Skip to content
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Menu
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Contact
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Menu
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Search
Close
Search
Close
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY
Menu
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY

Cryptococcal disease

Diseases A-Z Index Cryptococcal disease

Diseases A-Z Index:
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • W
  • V
  • X
  • Y
  • Z

What is Cryptococcal disease?

Cryptococcal disease is caused by the fungus Cryptococcus. The fungus is found worldwide in the environment in places such as decaying organic matter, trees, soil and bird droppings. The disease is mostly caused by two species of Cryptococcus: Cryptococcus neoformans and Cryptococcus gattii. People inhale this fungi from the air in the form of fungal spores. The fungi remain inactive until the person’s immune system is weakened, such as in transplant recipients or persons with untreated HIV.  People with intact immune systems can sometimes also get the disease, although these cases are less common.

When the fungus is active, it can spread to the brain and sometimes other organs through the bloodstream. Meningitis, or inflammation of the brain and spinal cord, is the most common disease that is caused by this fungus. Cryptococcal meningitis is a major cause of death in HIV-infected individuals worldwide (second only to TB), despite the now widespread use of antiretroviral therapy (ART). It is also important to note that if a person is HIV-positive, they should continue taking ART. If a person is diagnosed with cryptococcosis, then the antifungal drugs fluconazole and amphotericin B can be prescribed to treat it. It is important to diagnose and treat cryptococcosis early so that it does not develop into life-threatening meningitis.

Cryptococcosis FAQ document (2017)
Guideline for the prevention, diagnosis and management of
cryptococcal meningitis among HIV-infected persons (2013)

Additional Documents:

Management of HIV-associated cryptococcal disease in
South Africa, Govender et al, (2014)

Share

Share on facebook
Share on twitter
Facebook Instagram Linkedin Twitter Youtube

Quick Links

  • M&E Dashboard
  • Publications
  • Vacancies
  • Researcher Directory
  • Terms and Conditions

Download NMC

  • Android App
  • Huawei App
  • Web Portal
  • Apple App

Connect with our Researchers

Contact Us

© NICD 2021. All Rights Reserved
Disclaimer: The National Institute for Communicable Diseases does not provide Medical Advice to the public. For Medical Advice, please consult your Healthcare provider.